Physician

Ajay Veeragandham, MD

According to 2025 Medicare claims, Ajay Veeragandham, MD (NPI: 1558467571) practices psychiatry in the Fayetteville, NC market, with the plurality of this provider's patient population coming from Cumberland, NC. This provider's primary affiliated billing organization is COASTAL CAROLINA NEUROPSYCHIATRIC CENTER, PA (NPI: 1184737462; TIN: 205374475) and primary practice location at 28304-4403.

Veeragandham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 122 traditional Medicare patients, billed 393 HCPCS/CPT codes, and received $32,820 in Medicare payments. The top billing code was 90792 (Psychiatric diagnostic evaluation with medical services). Part D data shows 4,197 prescription claims across 307 beneficiaries totaling $311,663 in drug costs, led by Invega Sustenna (Paliperidone Palmitate). Open Payments data shows 263 records totaling $4,185. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $57,992 to $32,820. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$32K$64K2015 Medicare payment: $57,992 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $59,419 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $59,837 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $63,757 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $50,404 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $49,557 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $53,691 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $43,657 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $34,990 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $32,820 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152731,134$57,992
20162971,171$59,419
20173401,286$59,837
20182861,170$63,757
2019238931$50,404
2020237875$49,557
2021182774$53,691
2022192622$43,657
2023157552$34,990
2024122393$32,820

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$265K$529K2015 Drug cost: $506,382 (USD; Tot_Drug_Cst)2016 Drug cost: $371,912 (USD; Tot_Drug_Cst)2017 Drug cost: $458,439 (USD; Tot_Drug_Cst)2018 Drug cost: $490,977 (USD; Tot_Drug_Cst)2019 Drug cost: $451,796 (USD; Tot_Drug_Cst)2020 Drug cost: $529,139 (USD; Tot_Drug_Cst)2021 Drug cost: $451,299 (USD; Tot_Drug_Cst)2022 Drug cost: $460,096 (USD; Tot_Drug_Cst)2023 Drug cost: $454,102 (USD; Tot_Drug_Cst)2024 Drug cost: $311,663 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152663,347$506,382
20162403,115$371,912
20172843,578$458,439
20182863,809$490,977
20192403,132$451,796
20202853,640$529,139
20212593,888$451,299
20222974,087$460,096
20233164,370$454,102
20243074,197$311,663

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90792Psychiatric diagnostic evaluation with medical services3434$121
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more114344$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1215$36

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Invega SustennaPaliperidone Palmitate16410$57,507
VraylarCariprazine Hcl281,080$52,187
RexultiBrexpiprazole15570$27,477
FanaptIloperidone11308$18,421
Clozapine OdtClozapine11330$12,206

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.263$4,185Otsuka America Pharmaceutical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ajay Veeragandham, MD?

Tedicare shows public-source Medicare data for Ajay Veeragandham, MD (NPI 1558467571), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajay Veeragandham, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ajay Veeragandham, MD?

Ajay Veeragandham, MD is linked to COASTAL CAROLINA NEUROPSYCHIATRIC CENTER, PA (billing NPI 1184737462) in the available physician profile data.

Does Ajay Veeragandham, MD have Open Payments data?

Ajay Veeragandham, MD has 263 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.